Clinical trials: White Coat Hypertension
Cardiovascular Diseases, Heart Diseases
White Coat Hypertension and Antihypertensive Treatment Effect - SCOR in Hypertension
To investigate the mechanisms of white coat hypertension and study it further as a risk factor for heart damage.
- Conditions
- Cardiovascular Diseases, Heart Diseases, Hypertension
- Trial name
- NCT00005316
- Sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
White Coat Hypertension, Hypertension
Virtual Reality as a Tool to Lower Blood Pressure and Anxiety in Clinic Settings
This clinical trial aims to evaluate whether a calming virtual reality (VR) experience can reduce office blood pressure (OBP) and anxiety in adults undergoing ambulatory blood pressure monitoring (ABPM) at Mayo Clinic in Florida.
- Conditions
- White Coat Hypertension, Hypertension, Blood Pressure, Anxiety
- Trial name
- NCT06960057
- Testing
- Virtual Reality Exposure
- Where
- United States
- Volunteers
- 79 people
- Sponsor
- Mayo Clinic
Hypertension
Stopping Antihypertensive Treatment amOng Hypertensive Patients in Primary Care (STOP-Trial)
The STOP-Trial is a prospective multicenter nonrandomized open study on grade I hypertension, performed by General practitioners.
- Trial name
- NCT02268071
- Testing
- Antihypertensive treatment will be stopped for 1 year unless hypertension recurrence
- Where
- 24 sites in France
- Volunteers
- 403 people
- Sponsor
- Central Hospital, Nancy, France
Transient Hypertension
Effect of Midazolam on White-coat Hypertensive Dental Patients
Intravenous sedation was used for dealing with transient hypertension, so-called white-coat hypertension, before dental treatment.
- Trial name
- NCT01528371
- Testing
- Midazolam, Normal Saline Solution (NSS)
- Where
- Japan
- Volunteers
- 40 people, healthy volunteers welcome
- Sponsor
- Okayama University
Hypertension, Obesity
Renal Response to Lower Body Negative Pressure in Pre-hypertensive States
The purpose of this study is to determine whether in pre-hypertensive and hypertensive states such as white coat hypertension, obesity related hypertension or resistant hypertension, renal function is more sensitive to…
- Conditions
- Hypertension, Obesity, White Coat Hypertension, Resistant Hypertension
- Trial name
- NCT01734096
- Testing
- Lower body negative pressure (LBNP), Candesartan cilexetil
- Where
- 2 sites in Switzerland
- Volunteers
- 78 people, healthy volunteers welcome
- Sponsor
- PD Dr. Grégoire Wuerzner
Hypertension,Essential, White Coat Hypertension
Implementing Hypertension Screening Guidelines in Primary Care
The goal of this study is to use a cluster-randomized design (1:1 ratio) among 8 primary care clinics affiliated with New York-Presbyterian Hospital to test the effectiveness of a theory-informed multifaceted implementation…
- Trial name
- EMBRACE (NCT03480217)
- Testing
- Multifaceted Implementation Strategy, Usual care
- Where
- 2 sites in United States
- Volunteers
- 1,186 people
- Sponsor
- Columbia University
Hypertension, Uncontrolled Hypertension
Use of Automated Office Blood Pressure Monitoring
Blood pressure measurements by three methods Office Blood Pressure Measurement (OBPM), Automated Office Blood Pressure Measurement (AOBPM), and Home Blood Pressure Measurement (HBPM) were collected retrospectively across three…
- Conditions
- Hypertension, Uncontrolled Hypertension, Hypertension, White Coat, Hypertension, Resistant to Conventional Therapy
- Trial name
- NCT05395403
- Testing
- Blood pressure measurement device
- Where
- United States
- Volunteers
- 28 people
- Sponsor
- University of Alabama at Birmingham
NAFLD; Hypertension, White-coat Hypertension, Masked Hypertension
24-h-ambulatory Blood Pressure Monitoring and Pulse Wave Analysis in NAFLD Patients
Evaluation of the individual cardiovascular risk profile of patients with non-alcoholic fatty liver disease (NAFLD) using 24-hour ambulatory long-term blood pressure measurement and pulse wave analysis
- Trial name
- HyperNAFLD (NCT04543721)
- Testing
- 24-h-ABPM
- Where
- Germany
- Volunteers
- 200 people
- Sponsor
- University Hospital of Cologne
Kidney Transplant, Familial Hypercholesterolaemia
Cardiovascular Risk in Children With Chronic Conditions Study
Children living with chronic health conditions face a higher risk of developing cardiovascular diseases than their peers, largely due to the accelerated aging of the heart and blood vessels.
- Conditions
- Kidney Transplant, Familial Hypercholesterolaemia, Type 1 Diabetes Mellitus (T1DM), Type 2 Diabetes Mellitus (T2DM)
- Trial name
- CR3C (NCT07086989)
- Where
- 3 sites in Hungary
- Volunteers
- 300 people
- Sponsor
- Semmelweis University
Hypertension, Chronic Kidney Diseases
Home Blood Pressure (HBP)-Guided Management of Hypertension in Stage 3-4 CKD
It is estimated that over 25% of the world's population had hypertension in the year 2000 and that this proportion will reach 30% in the year 2025.
- Trial name
- NCT03588520
- Testing
- Home Blood Pressure Monitoring
- Where
- Greece
- Volunteers
- 70 people
- Sponsor
- Aristotle University Of Thessaloniki
Blood Pressure, Lifestyle Risk Reduction
Blood Pressure Control in ESH Excellence Centres
In the BP-CON-ESH study we are going to include and analyze treated hypertensive patients seen consecutively by the ESH Excellence Centres.
- Conditions
- Blood Pressure, Lifestyle Risk Reduction, White Coat Hypertension
- Trial name
- BP-CON (NCT04295434)
- Where
- 46 sites in Armenia, Austria and 20 more
- Volunteers
- 3,000 people
- Sponsor
- Clinical Hospital Centre Zagreb
Prehypertension
Prehypertension Labeling
The purpose of this study is to find out whether labeling adults with prehypertension has negative effects on clinic blood pressure and quality of life 3 months after diagnosis.
- Trial name
- Tanya K23 (NCT01434953)
- Testing
- Labeled prehypertension, Unlabeled prehypertension
- Where
- United States
- Volunteers
- 100 people, healthy volunteers welcome
- Sponsor
- Columbia University
White Coat Hypertension
White-coat Hypertension in Childhood - Effects on Blood Pressure and Organ Damage
White coat hypertension, WCH means that the blood pressure are above normal values only when measured at visits to the doctor, but not at home.
- Trial name
- WCH (NCT05919420)
- Volunteers
- 56 people
- Sponsor
- Karolinska Institutet
Pregnancy in Diabetics
Blood Pressure, Antihypertensive Treatment and Preeclampsia in Pregnant Wom-en With Pre-existing Diabetes
Aim: First, to investigate the prevalence of a) confirmed hypertension, b) white coat hypertension and c) normal blood pressure in pregnant women with pre-existing diabetes.
- Trial name
- NCT02890836
- Testing
- Antihypertensiva, mainly Metyldopa
- Where
- Denmark
- Volunteers
- 513 people, healthy volunteers welcome
- Sponsor
- Copenhagen University Hospital, Rigshospitalet
Essential Hypertension, White Coat Hypertension
Heart Rate Variability in White Coat Hypertension and Essential Hypertension
The aim of the study is to investigate heart rate variability in patients with white coat hypertension and patients with essential hypertension.
- Conditions
- Essential Hypertension, White Coat Hypertension, Healthy
- Trial name
- NCT00286884
- Testing
- Monitoring of heart rate variability
- Where
- Denmark
- Volunteers
- 65 people, healthy volunteers welcome
- Sponsor
- Regional Hospital Holstebro
Hypertension
Real-World Validation of Huawei Wearable Technologies for Hypertension Risk Screening in Malaysia
Background: Hypertension (high blood pressure) is a major risk factor for heart disease and stroke, yet many people do not know they have it.
- Trial name
- Huawei-SunU1 (NCT07785895)
- Where
- Malaysia
- Volunteers
- 500 people, healthy volunteers welcome
- Sponsor
- Sunway University
Hypertension, Resistant to Conventional Therapy
Autonomic Dysfunction in Resistant Hypertension
The contribution of this study is the unedited evaluation of the circadian autonomic profiles of resistant hypertension with and without white-coat response.
- Trial name
- RH (NCT01833429)
- Where
- Brazil
- Volunteers
- 44 people
- Sponsor
- University of Campinas, Brazil
White Coat Hypertension
Short Term Reproducibility of Office White-coat Effect
While a theoretical increase in systolic blood pressure (BP) of 10 mmHg can triple the relative risk of cardiovascular disease (CVD), the potential presence of a white coat effect (WCE) can interfere with the assessment of blood…
- Trial name
- REBBRE (NCT06523062)
- Testing
- blood pressure measurement
- Volunteers
- 922 people, healthy volunteers welcome
- Sponsor
- University Hospital, Caen